The Weekly Market Review | August 30, 2019 | $JNJ $ULTA $CPB

The Weekly Market Review | August 30, 2019 | $JNJ $ULTA $CPB

Nasdaq Leads Down Session; Ulta Beauty, Workday Earnings WeighПодробнее

Nasdaq Leads Down Session; Ulta Beauty, Workday Earnings Weigh

The Weekly Market Review | April 3, 2020 | $JNJ $ABT $ZM $LKПодробнее

The Weekly Market Review | April 3, 2020 | $JNJ $ABT $ZM $LK

Week In Review: August 30, 2019Подробнее

Week In Review: August 30, 2019

Продолжение обзора на трикотаж , качественные вещи по приятным ценам 🇮🇹🇮🇹🇮🇹Подробнее

Продолжение обзора на трикотаж , качественные вещи по приятным ценам 🇮🇹🇮🇹🇮🇹

Kenvue IPO a Johnson and Johnson Spinoff!Подробнее

Kenvue IPO a Johnson and Johnson Spinoff!

The Weekly Market Review | May 22, 2020 | $WMT $JNJ $LKПодробнее

The Weekly Market Review | May 22, 2020 | $WMT $JNJ $LK

Market Journal | August 30, 2019 (Full EpisodeПодробнее

Market Journal | August 30, 2019 (Full Episode

Re-convened meeting of the Local Review Body (31/10/24/) - 8th January 2025Подробнее

Re-convened meeting of the Local Review Body (31/10/24/) - 8th January 2025

Cramer’s Mad Dash on Johnson & Johnson: Wait to see how they do on the talc lawsuitПодробнее

Cramer’s Mad Dash on Johnson & Johnson: Wait to see how they do on the talc lawsuit

Rink Report: 3/3/19Подробнее

Rink Report: 3/3/19

Jim Cramer gives Johnson & Johnson his stamp of approvalПодробнее

Jim Cramer gives Johnson & Johnson his stamp of approval

The Weekly Market Recap feat. JPOW, RIV Capital, & SILO | Week Ending August 27, 2021Подробнее

The Weekly Market Recap feat. JPOW, RIV Capital, & SILO | Week Ending August 27, 2021

Eyeing for JNJ stock? Know why J&J is splitting into 2 companiesПодробнее

Eyeing for JNJ stock? Know why J&J is splitting into 2 companies

Jim Cramer weighs in on Johnson & Johnson's Covid-19 vaccine trial resultsПодробнее

Jim Cramer weighs in on Johnson & Johnson's Covid-19 vaccine trial results